Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimal shutdown strategies for COVID-19 with economic and mortality costs: BC as a case study

M.T. Barlow, N.D. Marshall, R.C. Tyson
doi: https://doi.org/10.1101/2020.11.25.20239004
M.T. Barlow
1Department of Mathematics, University of British Columbia, Vancouver, BC V6T 1Z2, Canada ()
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barlow@math.ubc.ca
N.D. Marshall
2Dept of Mathematics and Statistics, McGill University, 805 Sherbrooke St. West, Montreal, Quebec H3A 0B9, Canada ()
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: noah.marshall2@mail.mcgill.ca
R.C. Tyson
3CMPS Department, University of British Columbia Okanagan, 1177 Research Rd, Kelowna, BC V1V 1V7, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rebecca.tyson@ubc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Decision makers with the responsibility of managing policy for the COVID-19 epidemic have faced difficult choices in balancing the competing claims of saving lives and the high economic cost of shutdowns. In this paper we formulate a model with both epidemiological and economic content to assist this decision making process. We consider two ways to handle the balance between economic costs and deaths. First, we use the statistical value of life, which in Canada is about C$7 million, to optimise over a single variable, which is the sum of the economic cost and the value of lives lost. Our second method is to calculate the Pareto optimal front when we look at the two variables – deaths and economic costs.

In both cases we find that, for most parameter values, the optimal policy is to adopt an initial shutdown level which reduces the reproduction number of the epidemic to close to 1. This level is then reduced once a vaccination program is underway. Our model also indicates that an oscillating policy of strict and mild shutdowns is less effective than a policy which maintains a moderate shutdown level.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the NSERC Discovery Grant Program through grants numbered RGPIN-2016-03703 (MTB) and RGPIN-2016-05277 (RCT).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No such approval is required for this paper as the work is all mathematical.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 30, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimal shutdown strategies for COVID-19 with economic and mortality costs: BC as a case study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimal shutdown strategies for COVID-19 with economic and mortality costs: BC as a case study
M.T. Barlow, N.D. Marshall, R.C. Tyson
medRxiv 2020.11.25.20239004; doi: https://doi.org/10.1101/2020.11.25.20239004
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Optimal shutdown strategies for COVID-19 with economic and mortality costs: BC as a case study
M.T. Barlow, N.D. Marshall, R.C. Tyson
medRxiv 2020.11.25.20239004; doi: https://doi.org/10.1101/2020.11.25.20239004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (74)
  • Dermatology (49)
  • Emergency Medicine (148)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (176)
  • Epidemiology (4908)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (690)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (325)
  • Health Systems and Quality Improvement (209)
  • Hematology (87)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5414)
  • Intensive Care and Critical Care Medicine (334)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (130)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (203)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (788)
  • Public and Global Health (1833)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (258)
  • Rheumatology (88)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (39)